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Abstract
Background: Modulation of inflammation and oxidative stress appears to limit
sepsis-induced damage in experimental models. The kidney is one of the most
sensitive organs to injury during septic shock. In this study, we evaluated the
effect of N-acetylcysteine (NAC) administration in conjunction with fluid resuscitation
on renal oxygenation and function. We hypothesized that reducing inflammation
would improve the microcirculatory oxygenation in the kidney and limit the onset of
acute kidney injury (AKI).
Methods: Rats were randomized into five groups (n = 8 per group): (1) control group,
(2) control + NAC, (3) endotoxemic shock with lipopolysaccharide (LPS) without fluids,
(4) LPS + fluid resuscitation, and (5) LPS + fluid resuscitation + NAC (150 mg/kg/h). Fluid
resuscitation was initiated at 120 min and maintained at fixed volume for 2 h with
hydroxyethyl starch (HES 130/0.4) dissolved in acetate-balanced Ringer’s solution
(Volulyte) with or without supplementation with NAC (150 mg/kg/h). Oxygen
tension in the renal cortex (CμPO2), outer medulla (MμPO2), and renal vein was
measured using phosphorimetry. Biomarkers of renal injury, inflammation, and
oxidative stress were assessed in kidney tissues.
Results: Fluid resuscitation significantly improved the systemic and renal
macrohemodynamic parameters after LPS. However, the addition of NAC further improved
cortical renal oxygenation, oxygen delivery, and oxygen consumption (p< 0.05). NAC
supplementation dampened the accumulation of NGAL or L-FABP, hyaluronic acid,
and nitric oxide in kidney tissue (p < 0.01).
Conclusion: The addition of NAC to fluid resuscitation may improve renal oxygenation
and attenuate microvascular dysfunction and AKI. Decreases in renal NO and hyaluronic
acid levels may be involved in this beneficial effect. A therapeutic strategy combining
initial fluid resuscitation with antioxidant therapies may prevent sepsis-induced AKI.
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Background
Inflammation is a key process in the pathophysiology of septic shock [1]. The whole
activation of leukocytes, the cascade of inflammation, the associated cytokine storm,
and endothelial cell dysfunction collaborate to alter the microcirculation [2, 3]. Subse-
quently, tissue hypoxia and dysoxia due to heterogeneity of the microcirculation will
occur [4]. Fluid resuscitation may not only help resolve some of these issues but also
lead to the activation of oxidative pathways in itself, resulting in a heterogeneous distri-
bution of blood flow and tissue oxygenation, especially in the renal cortex [5, 6].
Because reactive oxygen species (ROS) participate in the pathophysiology of endotoxemic
shock, it has been suggested that moderating the oxidative stress and inflammatory reaction
would translate into improving the microcirculation and oxygenation of the tissues. Previ-
ous studies have demonstrated an interest in the use of antioxidants for preventing sepsis-
induced damage in these organs [7–9]. Indeed, the experimental literature is full of studies
of drugs that target and are effective at dampening inflammation and oxidative stress. Some
trials have reported several anti-inflammatory or antioxidant drugs with discordant effects
on major outcomes [10, 11]. In fact, antioxidant therapies for specific organs might be of
interest. Acute kidney injury (AKI) and acute lung injury are particularly common compli-
cations of sepsis, and the development of either increases mortality probably because these
organs are more sensitive to inflammation and oxidative stress insults. Thus, the kidney
could benefit from antioxidant drugs.
A common approach for the inhibition of oxidant-mediated injury is the use of
glutathione-modulating agents such as sulfhydryl or thiol compounds. Among all the
drugs used to interact with this pathway, N-acetylcysteine (NAC) is the most studied
for its lung and renal protective effects [12–16]. NAC is a thiol compound with antioxidant
and vasodilatory properties [12]. NAC is regarded as an important antioxidant as it is a
source of sulfhydryl and glutathione groups in cells and, due to its interaction with ROS, is
a scavenger of free radicals. In septic patients, the endogenous antioxidant glutathione is
depleted [17]. Decreased levels of glutathione may lead to decreased protection of cell
membranes against oxygen radicals. NAC serves as a precursor of glutathione and
can replenish the intracellular glutathione stores [12]. Moreover, NAC targets kidney
microcirculatory blood flow [18, 19]. NAC has also been widely studied for its
nephroprotective effects in various settings.
Hypoxia and inflammation have an interdependent relationship. Several molecular
pathways of cross-talk between hypoxia and inflammation in the kidney have been
identified [20–22]. From a physiological perspective, although hypoxia may lead to
inflammation and vice versa, it is unclear whether correcting or modulating either of
these states would translate into better tissue oxygenation and improved outcomes.
NAC would be interesting for testing whether the modulation of inflammation could
correct tissue hypoxia during sepsis.
To date, no study has focused on tissue oxygenation in specific organs such as the
kidney but rather demonstrated that either pretreatment or post-treatment with NAC
decreased the markers of organ injury. In this study, we assessed kidney tissue oxygenation
in an endotoxemic shock model resuscitated with balanced hydroxyethyl starch—Ringer’s
acetate either with or without supplementation with NAC. We sought to promote blood
flow and oxygenation to the organs by the means of reducing inflammation and
oxidative stress.
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Methods
Animals
All experiments in this study were approved by the institutional Animal Experimentation
Committee of the Academic Medical Center of the University of Amsterdam (DFL102538).
The care and handling of the animals were in accordance with the guidelines for
Institutional Animal Care and Use Committees. The study was conducted in accordance
with the Declaration of Helsinki. Experiments were performed on albino Wistar rats (Harlan
Netherlands BV, Horst, The Netherlands) with a mean ± SD body weight of 325 ± 6 g.
Surgical preparation
All animals were anesthetized with an intraperitoneal injection of a mixture of 90 mg/kg
ketamine (Nimatek®, Eurovet, Bladel, The Netherlands), 0.5 mg/kg dexmedetomidine
(Dexdomitor, Pfizer Animal Health BV, Capelle aan den IJssel, The Netherlands), and
0.05 mg/kg atropine-sulfate (Centrafarm Pharmaceuticals BV, Etten-Leur, The
Netherlands). After a tracheotomy was performed, the animals were mechanically
ventilated with a fraction of inspired oxygen (FiO2) of 0.4. Body temperature was
maintained at 37 ± 0.5 °C during the entire experiment by an external thermal heating
pad. Ventilator settings were adjusted to maintain an arterial partial pressure of
carbon dioxide (PaCO2) between 35 and 40 mmHg. For drug and fluid administration
as well as hemodynamic monitoring, vessels were cannulated with polyethylene catheters
with an outer diameter of 0.9 mm (Braun, Melsungen, Germany). A catheter in the right
carotid artery was connected to a pressure transducer to monitor the mean arterial blood
pressure (MAP) and heart rate. The right jugular vein was cannulated for continuous
infusion of Ringer’s lactate (Baxter, Utrecht, The Netherlands) at a rate of 15 ml/kg/h and
for the maintenance of anesthesia. The right femoral artery was cannulated for drawing
blood samples; the right femoral vein, for drug administration. The left kidney was
exposed, decapsulated, and immobilized in a Lucite kidney cup (K. Effenberger, Pfaffingen,
Germany) via an ~4-cm incision in the left flank in each animal. Renal vessels were care-
fully separated to preserve the nerves and adrenal gland. A perivascular ultrasonic transi-
ent time flow probe was placed around the left renal artery (type 0.7 RB Transonic
Systems Inc., Ithaca, NY, USA) and connected to a flow meter (T206, Transonic Systems
Inc., Ithaca, NY, USA) to continuously measure renal blood flow (RBF). The left ureter
was isolated, ligated, and cannulated with a polyethylene catheter for urine collection.
After the surgical preparation, one optical fiber was placed 1 mm above the decapsulated
kidney, and another optical fiber was placed 1 mm above the renal vein to measure renal
microvascular and venous oxygenation using phosphorimetry. A small piece of aluminum
foil was placed on the dorsal side of the renal vein to prevent the underlying tissues from
contributing to the phosphorescence signal in the venous PO2 measurements. The surgi-
cal field was covered with a humidified gauze compress throughout the entire experiment
to prevent drying of the exposed tissues.
Experimental protocol
After a 30-min stabilization, the rats were randomized into the five following groups at
baseline: (1) control group, (2) control +NAC, (3) endotoxemic shock with lipopolysaccharide
(LPS) without fluid resuscitation, (4) LPS + fluid resuscitation, and (5) LPS + fluid
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resuscitation + NAC (150 mg/kg/h). The groups received either an intravenous bolus
of 5 mg/kg LPS (LPS group; Escherichia coli 0127:B8, Sigma, Paris, France; three
groups of eight rats each) or vehicle (control group, two groups of eight rats each).
Animals were observed or kept in shock for over 120 min. Fluid resuscitation (15 ml/kg/h)
was then started and maintained for 180 min in the LPS groups with 6 % hydroxyethyl
starch (HES130/0.4) dissolved in Ringer’s acetate (HES-RA; Volulyte® 6 %, Fresenius Kabi
Deutschland GmbH, Germany) as a balanced colloid solution. NAC was administered to
the appropriate groups at a rate of 150 mg/kg/h as previously reported [15]. An LPS group
was not resuscitated to serve as a shock control. Time points for the measurements were
baseline (T0), during shock 120 min after administration of LPS (T1), 30 min after initiating
fluid resuscitation (early reperfusion phase) (T2), and 120 min after starting fluid resuscita-
tion (late reperfusion phase) (T3), which was the final endpoint of the experiment (Fig. 1).
Blood gas measurements and biochemistry
Arterial blood samples of 0.5 ml were collected from the femoral artery at T0, T1, T2,
and T3. The blood samples were replaced by the same volume of balanced colloid solution.
The samples were used to determine blood gas parameters (Radiometer ABL 505 Blood
Gas Analyzer, Copenhagen, Denmark). The hematocrit and the levels of potassium,
bicarbonate, and the anion gap were recorded by the analyzer.
Measurement of renal microvascular oxygenation and venous PO2
The renal microvascular partial pressure of oxygen (μPO2) and renal venous PO2
(rvPO2) were measured by oxygen-dependent quenching of phosphorescence lifetimes
of the phosphorescent dye Oxyphor G2 (Oxygen Enterprises Ltd., Philadelphia, PA,
USA) as described previously [23, 24]. A total of 6 mg/kg IV over 5 min was adminis-
tered followed by 30 min of stabilization before recording baseline measurements.
Calculation of derivatives of oxygenation parameters and renal vascular resistance
Renal oxygen delivery was calculated using the following formula: DO2ren (ml/min) =
RBF × arterial oxygen content (1.31 × hemoglobin × SaO2) + (0.003 × PaO2), where
SaO2 is the arterial oxygen saturation and PaO2 is the arterial partial pressure of oxygen.
Renal oxygen consumption was calculated using the following formula: VO2ren
(ml/min/g) = RBF × (CaO2 − CvO2), where the renal venous oxygen content (CvO2)
was calculated as (1.31 × hemoglobin × SrvO2) + (0.003 × rvPO2). The SrvO2ren was
calculated using the Hill equation with P50 = 37 Torr (4.9 kPa) and the Hill coef-
ficient = 2.7. An estimation of the renal vascular resistance (RVR) was defined as
RVR (dynes sec cm−5) = (MAP/RBF) × 100.
Fig. 1 Timeline of the experimental protocol
Ergin et al. Intensive Care Medicine Experimental  (2016) 4:29 Page 4 of 17
Assessment of kidney function
Creatinine clearance (Clcrea [ml/min]) was assessed as an index of the glomerular filtra-
tion rate. Clearance was calculated using the following formula: Clcrea = (Ucrea ×V)/
Pcrea, where Ucrea is the concentration of creatinine in urine, V is the urine volume per
unit time, and Pcrea is the concentration of creatinine in the plasma. The renal energy
efficiency for sodium transport (VO2/TNa) was assessed using a ratio calculated from
the total amount of VO2 over the total amount of sodium reabsorbed (TNa, mmol/min)
according to the following formula: (Clcrea × PNa) −UNa ×V.
NO metabolism
The index of total nitric oxide (NO) production is the sum of both nitrite and nitrate
accumulated in tissue samples. To determine this index, a saturated solution of van-
adium (III) chloride (VCl3) in 1 mol/l HCl was used as a reducing agent. At a
temperature of 90 °C, the VCl3 reagent quantitatively converts nitrite, nitrate, and S-
nitroso compounds to NO in a glass reaction vessel. NO was then flushed out of the
reaction vessel by the flow of helium gas and was then measured using a Sievers NO
analyzer (General Electric Company, GE Water & Process Technologies Analytical
Instruments) to detect chemiluminescence as the amount of light from the ozone-NO
reaction in the measurement chamber of the analyzer. NO levels were determined in
homogenized frozen kidney tissues. A ratio of tissue NO to tissue protein content was
used for standardization of NO release per gram of protein.
Glycocalyx component assessments
Hyaluronan is the main component of the endothelial glycocalyx, and alterations in its
concentration are attributed to glycocalyx volume loss. Inhibition of tumor necrosis
factor-alpha protects against endotoxin-induced endothelial glycocalyx perturbation.
Plasma hyaluronan concentrations were determined using a Corgenix hyaluronic acid
test kit (Corgenix Inc., Westminster, CO, USA) based on an enzyme-linked hyaluronic
acid-binding protein assay.
Measurement of oxidative stress and inflammatory cytokines
All kidneys were homogenized in cold 5 mM sodium phosphate buffer. The homogenates
were centrifuged at 12,000g for 15 min at 4 °C, and the supernatants were used to deter-
mine TNF-α, IL-6, hyaluronic acid, malondialdehyde (MDA), and protein carbonyl levels.
The levels of these markers were expressed as per gram of protein (Bradford assay).
To determine the oxidative stress and inflammatory cytokines levels, enzyme-linked
immunosorbent assay (ELISA) kits were used. Tumor necrosis factor-α (TNF-α)
(DY510, R&D system, Inc. Minneapolis, USA), interleukin-6 (IL-6) (DY506, R&D sys-
tem, Inc. Minneapolis, USA), tissue MDA, and protein carbonyl were determined in
homogenized tissue samples.
Immunohistochemical analysis
Kidney tissues were fixed in 4 % formalin and embedded in paraffin. After preparation,
kidney sections were incubated with a neutrophil gelatinase-associated lipocalin (NGAL)
antibody (NGAL antibody 41105, Abcam, Cambridge, UK) and a polyclonal antibody to
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rat liver-type fatty acid protein (L-FABP) (HP8010, Hycult Biotect, Uden Holland). Anti-
bodies were diluted in a large volume of UltrAb Diluent (TA-125-UD, Thermo Fisher
Scientific, Breda, Holland). The slides were counterstained with Mayer’s hematoxylin
(LabVision TA-125-MH Thermo Fisher Scientific, Breda, Holland) and mounted in a
vision mount (LabVision, TA-060-UG, Thermo Fisher Scientific, Breda, Holland) after
washing in distilled water. Both the intensity and the distribution of L-FABP and NGAL
staining were scored. For each sample, a histological score (HSCORE) value was derived
by summing the percentages of cells that were stained at each intensity multiplied by the
weighted intensity of the staining: HSCORE = S Pi (i + 1), where i is the intensity score
and Pi is the corresponding percentage of the cells.
Statistical analyses
The results are expressed as the mean ± SD. Statistical significance was calculated by one-
way and two-way analysis of variance (ANOVA) followed by either Tukey’s or Bonferroni’s
multiple comparison tests using GraphPad Prism (GraphPad Prism, Version 5, Software
Program, San Diego, CA, USA). p < 0.05 was considered statistically significant.
Results
Systemic and renal hemodynamic parameters
The evolution of systemic and renal hemodynamics is presented in Table 1. Infusion of
LPS induced an early drop in the MAP (76.8 ± 9.3 mmHg versus 45.8 ± 7.9 mmHg, p <
0.001) and RBF (4.5 ± 1.5 ml/min versus 0.7 ± 0.6 ml/min, p < 0.001) in the control
group versus the LPS group, respectively, at T3. Fluid resuscitation with HES-RA both
with and without NAC significantly improved RBF compared to the LPS alone group
(p < 0.05). Both HES-RA and HES-RA +NAC significantly decreased the RVR com-
pared to LPS alone (p < 0.001). After LPS, the addition of NAC to the fluid did not re-
sult in improved hemodynamic parameters compared to fluid resuscitation alone. The
infusion of NAC led to a decrease in the MAP in the absence of LPS (57.3 ± 5.6 mmHg
versus 76.8 ± 9.3 mmHg in the control group, p < 0.001).
Renal microvascular oxygenation
The percentage variations in CμPO2, MμPO2, DO2ren, and VO2ren between baseline
(T0) and the end of the experiment (T3) are shown in Fig. 2. Compared to the control
groups, LPS infusion induced a significant decrease in CμPO2 (40.6 ± 8.8 mmHg versus
68.2 ± 4.1 mmHg in the control group at T3, p < 0.001) and MμPO2 (32.2 ± 7.9 mmHg
versus 51.6 ± 3.2 mmHg in the control group, p < 0.001). Fluid resuscitation with HES-RA
alone did not improve either CμPO2 or MμPO2. HES-RA combined with NAC signifi-
cantly improved CμPO2 during sepsis (p < 0.01). LPS induced a significant decrease in
DO2ren and VO2ren (8.3 ± 6.1 ml O2/min in the LPS group versus 67.2 ± 23.2 ml O2/min
in the control group at T3 and 7.8 ± 6.5 ml O2/min in the LPS group versus 32.9 ± 10 ml
O2/min in the control group at T3, p < 0.05, respectively). Fluid resuscitation with or with-
out NAC significantly improved VO2ren compared to the LPS alone group (p < 0.05). Of
note, the addition of NAC to the control group also increased VO2ren compared to the
control group alone (p < 0.05). The hematocrit values are reported in Table 3. A signifi-
cant decrease in hematocrit occurred after fluid resuscitation in both groups compared to
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the control and LPS alone groups (p < 0.001). The magnitude of hemodilution in both
groups was in the same range.
LPS induced a significant increase in ER% O2 at T1, T2, and T3 compared to the control
group (p < 0.01, p < 0.01, and p < 0.001, respectively), and this value was only improved in
LPS + HES-RA group at T2. In the control group receiving NAC, ER%O2 was also
increased at T3 compared to control (p < 0.001).
Kidney function and biomarkers of kidney injury
The evolution of TNa+, VO2ren/TNa
+, ClCrea, and EFNa
+ at different time points is pre-
sented in Table 2. TNa+ levels were lower in the LPS, LPS + HES-RA, and LPS +HES +
RA +NAC groups (p < 0.001) than the control group at T1, T2, and T3. Fluid resuscita-
tion did not restore these values. The addition of NAC also decreased the TNa + in the
control + NAC group compared to the control group (p < 0.01). VO2ren/TNa
+ increased
in LPS groups receiving HES-RA and HES + RA +NAC at T3 compared to the control
group (p < 0.05 and p < 0.001, respectively) and the LPS alone group (p < 0.05 and p <
0.001, respectively). Compared to the control and LPS alone groups, EFNa+ values were
increased in the LPS groups treated with HES-RA with and without NAC at T2 and T3.
NAC administration in the control group tended to decrease TNa+ and EFNa+ without
reaching a significant level. Fluid resuscitation improved urine output regardless of the
addition of NAC compared to the LPS group (p < 0.001). No effect of NAC on urine
output was noted in the control + NAC group compared to the control group, but a
significant decrease in Clcreat was observed (p < 0.001).
Table 1 Evolution of systemic and renal hemodynamics parameters during the experiment
T0 (baseline) T1 (shock) T2 (30 min) T3 (120 min)
MAP (mmHg)
Time control 102 ± 9.0 86.3 ± 13.4 80.1 ± 8.8 76.8 ± 9.3
Control + NAC 87.7 ± 7.6 75.3 ± 10.5 70.5 ± 8.0 57.3 ± 5.6***
LPS 101 ± 11.1 56.8 ± 10.5*** 53.7 ± 9.4*** 45.8 ± 7.9***
LPS + HES-RA 92.1 ± 8.7 55.6 ± 9.5*** 65.5 ± 4.9*, + 51.6 ± 3.7***
LPS + HES-RA + NAC 98.8 ± 8.7 49.8 ± 8.5*** 64.1 ± 4.7** 52.6 ± 6.1***
RBF (ml/min)
Time control 5.4 ± 0.6 4.8 ± 0.8 5.3 ± 0.9 4.5 ± 1.5
Control + NAC 5.7 ± 0.7 4.3 ± 0.9 4.8 ± 1.5 4 ± 1.1
LPS 5.7 ± 1.4 1.3 ± 0.7*** 1.4 ± 0.5*** 0.7 ± 0.6***
LPS + HES-RA 6.6 ± 0.3 1.9 ± 1.5*** 5.6 ± 1.8+++ 5.0 ± 0.4+++
LPS + HES-RA + NAC 5.5 ± 0.4 1 ± 0.4*** 3.5 ± 0.9*, ++ 4.8 ± 2.2+++
RVR )dyn.s.sec−5)
Time control 1910.2 ± 260.5 1793.7 ± 227.4 1524.3 ± 188.2 1861.3 ± 751.2
Control + NAC 1548.6 ± 249.2 1782.6 ± 368.6 1606.7 ± 583.2 1521.9 ± 511.1
LPS 1774.8 ± 302.4 5911.5 ± 3333.4*** 4182.9 ± 829.7* 10,372 ± 5182.2***
LPS + HES-RA 1410 ± 152.2 3293.2 ± 1978.9+ 1130.2 ± 348.1++ 1004.3 ± 48.3+++
LPS + HES-RA + NAC 1787.2 ± 236 5795.8 ± 2517.4*** 1909.8 ± 375.7 1199.1 ± 318.3+++
LPS lipopolysaccharide, HES-RA hydroxyethyl starch-ringer acetate, NAC N-acetylcysteine
Values are presented as mean ± SD *p < 0.05, **p < 0.01, and ***p < 0.001 control versus other groups; +p < 0.05,
++p < 0.01, and +++p < 0.001 LPS versus other groups
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Biomarkers of AKI (NGAL and L-FABP) were significantly increased in the kidney after
LPS infusion (p < 0.05 and p < 0.001, respectively, versus the control group) (Fig. 3). The re-
suscitation fluid combined with NAC significantly decreased these biomarkers compared to
the LPS alone group (p < 0.001 and <0.05, respectively). Moreover, L-FABP was lower in the
group of septic rats resuscitated with HES-RA+NAC than with HES-RA alone (p < 0.001).
Plasma electrolytes and acid-base status
Bicarbonate and plasma lactate levels, pH, base excess, and anion gap with K+ are shown in
Table 3. LPS infusion significantly increased the plasma lactate level and anion gap, which
could not be corrected by the administration of HES-RA either with or without NAC (p <
0.001) compared to the control group. Base excess, pH, and bicarbonate levels were simi-
larly decreased after LPS infusion and were partially corrected by fluid resuscitation. NAC
infusion alone in the control group resulted in a significant decrease in pH, base excess, and
bicarbonate levels compared to the control group (p < 0.01). NAC administration worsened
the acid-base status in the LPS resuscitated and control groups. The level of bicarbonate
Fig. 2 Percentage change of renal microvascular oxygen tension, oxygen delivery, and consumption from
baseline to T3. In the renal cortex (CμpO2) (a), in the medulla (MμpO2) (b), renal oxygen delivery
(DO2ren) (c), and renal oxygen consumption (VO2ren) (d). *p < 0.05, **p < 0.01, *p < 0.001 versus
control; +p < 0.05 LPS versus LPS group
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and base excess were significantly lower in rats resuscitated with fluid plus NAC than with
fluid alone (p < 0.01).
Oxidative stress and inflammatory cytokines
The levels of biomarkers of oxidative stress, pro-inflammatory cytokines, and products
of glycocalyx degradation are represented in Fig. 4. The levels of TNF-α (3A) and IL-6
(3B) in kidney homogenates from the LPS group were significantly increased compared
to the control group (528.1 ± 143.9 pg/mg protein versus 291.8 ± 99.1 pg/mg protein, p <
0.05; and 1246 ± 441 pg/mg protein versus 753.8 ± 122 pg/mg protein, p < 0.05, respect-
ively). The same results were observed regarding hyaluronic acid (HA) (3C), nitric oxide
Table 2 Parameters of renal function and excretion at different time points of the experiment
T0 (baseline) T1 (shock) T2 (30 min) T3 (120 min)
TNa+ (mmol/min−1)
Time control 15.3 ± 9.6 14.1 ± 7.0 18.8 ± 6.8 19.7 ± 4.7
Control + NAC 15.0 ± 6.4 13.2 ± 6.5 15.9 ± 6.5 9.5 ± 4.3**
LPS 12.3 ± 5.5 0.00 ± 0.00*** 0.00 ± 0.00*** 0.00 ± 0.00***
LPS + HES-RA 12.0 ± 8.3 0.00 ± 0.00*** 5.0 ± 1.12*** 2.2 ± 1.3***
LPS + HES-RA + NAC 11.9 ± 5.7 0.00 ± 0.00*** 2.8 ± 2.8*** 2.2 ± 1.8***
VO2/TNa
+
Time control 1.77 ± 1.6 2.19 ± 1.3 1.59 ± 0.6 1.79 ± 0.7
Control + NAC 1.36 ± 0.4 2.19 ± 0.9 1.95 ± 1.18 6.32 ± 3.9
LPS 2.5 ± 1.2 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00
LPS + HES-RA 2.24 ± 1.1 0.00 ± 0.00 6.06 ± 1.7 17.17 ± 7.1*, +
LPS + HES-RA + NAC 1.97 ± 1.3 0.00 ± 0.0* 23.36 ± 22.2 28.53 ± 28***, +++
ClCrea (ml/min)
Time control 0.11 ± 0.6 0.10 ± 0.04 0.14 ± 0.04 0.14 ± 0.03
Control + NAC 0.11 ± 0.04 0.09 ± 0.04 0.11 ± 0.04 0.06 ± 0.03***
LPS 0.09 ± 0.04 0.00 ± 0.00*** 0.00 ± 0.00*** 0.00 ± 0.00***
LPS + HES-RA 0.09 ± 0.06 0.00 ± 0.00*** 0.05 ± 0.01***, + 0.02 ± 0.01***
LPS + HES-RA + NAC 0.09 ± 0.04 0.00 ± 0.00*** 0.04 ± 0.01*** 0.02 ± 0.01***
EFNa+
Time control 4.8 ± 4.7 13.2 ± 5.7 11.9 ± 4.9 10.4 ± 2.4
Control + NAC 2.3 ± 0.8 3.22 ± 1.7 2.9 ± 1.7 6.9 ± 6.6
LPS 3.7 ± 1.4 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00
LPS + HES-RA 3.5 ± 2.8 0.00 ± 0.00 35.3 ± 7.3**, +++ 17.1 ± 8.1
LPS + HES-RA + NAC 4.4 ± 3.9 0.00 ± 0.00 45.8 ± 36.7***, +++ 31.4 ± 28.4***, +++
Urine volume (ml)
Time control 0.39 ± 0.14 0.53 ± 0.13 0.45 ± 0.13 0.19 ± 0.03
Control + NAC 0.25 ± 0.09 0.34 ± 0.17 0.2 ± 0.04 0.16 ± 0.06
LPS 0.31 ± 0.13 0.06 ± 0.09*** 0.04 ± 0.05*** 0.02 ± 0.05***
LPS + HES-RA 0.37 ± 0.3 0.12 ± 0.19*** 0.6 ± 0.23+++ 0.16 ± 0.08+++
LPS + HES-RA + NAC 0.33 ± 0.26 0.04 ± 0.09*** 0.65 ± 0.47+++ 0.2 ± 0.13+++
Values are presented as mean ± SD
TNa+ tubular sodium reabsorption, Clcreat clearance of creatinine, LPS lipopolysaccharide, HES-RA hydroxyethyl starch-ringer
acetate, NAC N-acetylcysteine
*p < 0.05, **p < 0.01, and ***p < 0.001 versus control; +p < 0.05 and +++p < 0.001 versus LPS
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(3D), and MDA (3E) after LPS infusion (p < 0.05). The addition of NAC to HES-RA during
fluid resuscitation resulted in a significant lower level of HA and nitric oxide compared to
the LPS group (p < 0.01). Infusion of HES-RA alone decreased the levels of MDA compared
to LPS alone (p < 0.01) (3E). Protein carbonyl levels were not altered (3E).
Discussion
In the present study, we found that fluid supplemented with NAC improved cortical
renal oxygenation, oxygen delivery, and oxygen consumption compared to the LPS
group. Fluid resuscitation alone was partially effective in correcting kidney hypoxia but
did not reach a significant level compared to the LPS group. The addition of NAC to
the resuscitation fluid did not further improve systemic or renal hemodynamics com-
pared to HES-RA alone. It has been suggested that a specific effect of NAC on micro-
vascular oxygenation exists independent of renal macrovascular perfusion. In an
experimental study, Heyman et al. showed that NAC induced vasodilation in a pre-
constricted renal microvasculature rat model [18]. The vasculature may be similarly
constricted after LPS infusion leading to microcirculation heterogeneity [25]. Although
creatinine levels did not differ between septic rats receiving fluids either with or with-
out NAC, the fluid resuscitation combined with NAC decreased the levels of renal NO,
hyaluronic acid, and early markers of acute kidney injury such as NGAL or L-FABP.
Previous studies demonstrated a significant decrease in inflammatory biomarkers in
specific organs such as the lungs and kidneys in models of sepsis [14–16, 26–29]. How-
ever, none of these studies reported the beneficial effects of NAC on tissue oxygenation
during sepsis by decreasing oxidative stress and inflammation.
Several studies using microcirculatory techniques have now questioned the significance of
arterial RBF and have focused on the renal microcirculation as the hemodynamic culprit in
the pathophysiology of septic AKI [6, 25, 30]. Microcirculatory dysfunction may contribute
to renal hypoxia even in the absence of overt renal hypoperfusion. The microcirculation of
the renal cortex has been shown to be severely injured in animal models of sepsis. After
LPS infusion in rats, Legrand et al. showed that fluid resuscitation could not fully restore
renal microcirculatory dysfunction [6]. In dogs, endotoxemia was found to be associated
Fig. 3 Immunostaining intensity (HSCORE) of NGAL (a) and L-FABP (b) in kidney cortex of all groups.
*p < 0.05, ***p < 0.001 versus control group; +p < 0.05, +++p < 0.001 versus LPS group, ###p < 0.001
versus LPS + HES-RA group
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with renal hypoperfusion and hypoxia in the renal cortex but was concomitant with
increased renal venous PO2, supporting the concept that convective shunting of oxygen
may contribute to the development of tissue hypoxia [31]. In our study, the LPS-induced
renal microvascular heterogeneity and hypoxia appeared to be corrected with the NAC-
supplemented fluid.
Table 3 Time-course of acid-base status, lactate levels, and hematocrit resuscitated with and without
the addition of NAC
T0 (baseline) T1 (shock) T2 (30 min) T3 (120 min)
pH
Time control 7.37 ± 0.03 7.39 ± 0.06 7.42 ± 0.03 7.42 ± 0.04
Control + NAC 7.48 ± 0.12 7.42 ± 0.03 7.38 ± 0.02 7.32 ± 0.05*
LPS 7.36 ± 0.03 7.27 ± 0.06** 7.26 ± 0.07*** 7.2 ± 0.07***
LPS + HES-RA 7.36 ± 0.03 7.26 ± 0.07*** 7.31 ± 0.07* 7.27 ± 0.05***
LPS + HES-RA + NAC 7.37 ± 0.04 7.26 ± 0.09*** 7.27 ± 0.08*** 7.20 ± 0.03***
HCO3
− (mmol/L)
Time control 20.6 ± 0.9 21 ± 0.6 21.2 ± 1.3 21.6 ± 1.3
Control + NAC 18.8 ± 0.6 18.4 ± 1.5* 19.3 ± 1.2 14.2 ± 3.8***
LPS 20.2 ± 0.7 15 ± 0.9*** 15.3 ± 1.2*** 12.8 ± 0.5***
LPS + HES-RA 21.6 ± 0.7 14.8 ± 1.5*** 18.1 ± 0.9***, ++ 16.7 ± 1.6***, +++
LPS + HES-RA + NAC 20.7 ± 0.8 14.7 ± 2.5*** 16.6 ± 1.6*** 14 ± 1.7***, ##
Base excess (mmol/L)
Time control −3.5 ± 1.2 −2.7 ± 1.6 −1.7 ± 1.3 −1.8 ± 1.5
Control + NAC −3.5 ± 0.5 −4.4 ± 1.7 −4.5 ± 1.3 −8.9 ± 2.4***
LPS −4 ± 1.3 −10.8 ± 1.9*** −10.5 ± 1.7*** −14.1 ± 1.3***
LPS + HES-RA −2.9 ± 1.1 −11.3 ± 2.7*** −7 ± 2***, ++ −8.9 ± 1.9***, +++
LPS + HES-RA + NAC −3.4 ± 1.5 −11.2 ± 4.1*** −9.1 ± 2.8*** −12.5 ± 1.7***, ##
Anion gap K+ (mmol/L)
Time control 17.7 ± 0.8 18.0 ± 0.7 16.4 ± 0.5 16.8 ± 1.3
Control + NAC 18.9 ± 2.0 18.5 ± 2.0 17.0 ± 1.2 18.9 ± 4.8
LPS 18.9 ± 2.3 21.8 ± 1.1 21.6 ± 1.8 23.2 ± 1.6***
LPS + HES-RA 17.5 ± 1.3 22.7 ± 1.3 19.2 ± 1.0 20.9 ± 2.5***
LPS + HES-RA + NAC 18.4 ± 1.0 22.5 ± 2.5** 20.6 ± 2.3* 23.1 ± 1.9***
Lactate (mmol/L)
Time control 2.32 ± 0.52 2.22 ± 0.34 2.08 ± 0.31 1.73 ± 0.27
Control + NAC 3.10 ± 0.64 2.92 ± 0.76 2.17 ± 0.36 2.10 ± 0.33
LPS 2.42 ± 0.32 3.08 ± 0.28 3.08 ± 0.5 4.32 ± 0.6***
LPS + HES-RA 1.92 ± 0.2 3.32 ± 0.55 2.75 ± 0.48 5.08 ± 1.83***
LPS + HES-RA + NAC 2.70 ± 0.21 3.83 ± 1.36** 3.30 ± 1.17* 4.98 ± 1.21***
Hct (%)
Time control 49.6 ± 1.3 41.6 ± 1.9 39 ± 2.9 33.3 ± 3
Control + NAC 48.8 ± 2.6 42.8 ± 4.4 41.1 ± 4.2 33.8 ± 2.6
LPS 49.3 ± 4.0 39.6 ± 3.0 35.1 ± 2.9 34.0 ± 3.5
LPS + HES-RA 49.3 ± 1.7 43.3 ± 2.5 30.1 ± 4.5***, + 17.5 ± 3***, +++
LPS + HES-RA + NAC 48.6 ± 0.8 44.1 ± 3.2+ 33.0 ± 2.6** 18.0 ± 2.0***, +++
LPS lipopolysaccharide, HES-RA hydroxyethyl starch-ringer acetate, NAC N-acetylcysteine
Values are presented as mean ± SD, *p < 0.05, **p < 0.01, ***p < 0.001 versus control; ++p < 0.05, +++p < 0.001 versus LPS;
##p < 0.01 versus LPS + HES-RA
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We also observed negative effects of NAC infusion. Delayed hypotension occurred in
the control + NAC group, highlighting the vasodilatory effects of this compound as
previously described [12, 32]. The mechanism involved in this lowering effect might be
mediated by the interaction of sulfhydryl groups with enzymes such as the guanylate
cyclase, which is the primary receptor for NO [32]. This drop in the MAP may contribute
to tissue hypoperfusion and hypoxia as well as the lower pH observed in the control +
NAC group compared to the control group. However, no significant change was observed
Fig. 4 Levels of biomarkers of oxidative stress and pro-inflammatory cytokines in renal tissue. Renal tissue
TNF-α (a), IL-6 (b), hyaluronic acid (c), nitric oxide (d), MDA (e), and protein carbonyl (f). *p < 0.05, **p < 0.01,
***p < 0.001 versus control; +p < 0.05, ++p < 0.01 versus LPS group
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in renal blood flow measured in the renal artery. Conflicting data exist between experi-
mental and human clinical studies regarding the effects of NAC on regional blood flow
and cardiac output [19, 33–37]. First, NAC administration was shown to improve survival
in experimental models of peritonitis-induced sepsis [38, 39]. In mongrel dogs subjected
to endotoxemia, Zhang et al. demonstrated the myocardial protective effects of NAC
pretreatment (150 mg/kg) with enhanced oxygen delivery but lower systemic and pul-
monary pressures [37]. In contrast, in a study involving 20 patients with septic shock,
NAC infusion (150 mg/kg for 15 min followed by continuous infusion) that was initiated
within 24 h after the onset of septic shock resulted in a decrease in left ventricular stroke
work—revealing myocardial depression—without a significant impact on MAP at 48 h
after treatment initiation [33]. In a similar population, Rank et al. demonstrated the exact
opposite effect with an improvement in liver blood flow, oxygen delivery, and oxygen
consumption related to an increase in cardiac index [34]. However, the infusion of NAC
lasted less than 2 h in this latter study. Agustí et al. reported an increase in the cardiac
index associated with vasodilatation but without improvements in splanchnic micro-
circulation after NAC infusion in patients presenting with septic shock and multiple
organ failure [35]. Clinical studies yielded controversial results with the use of NAC
in sepsis [11]. NAC treatment during the first hours of sepsis or septic shock may
decrease peroxidative stress [40], improve hepatic function [34], and enhance tissue
oxygenation and cardiac function [41], whereas delayed administration adversely
affected the outcomes of critically ill patients with multiple organ failure [33, 42].
Most published studies have examined the effects of NAC when given as a pretreat-
ment, e.g., before the insult. Here, we evaluated the ability of NAC when administered
during the resuscitation process to correct tissue hypoxia and inflammation already
present. It seems that the beneficial effects on tissue oxygenation, if any, are not similar if
NAC is administered before or after the insult. The effects also depend on the time
elapsed since the insult. We showed that NAC-supplemented fluid did not provide
additional benefits on the acid status and renal function compared to fluid alone. Only
kidney oxygenation was significantly higher in the group receiving fluid supplemented
with NAC compared to the LPS alone group, whereas fluid alone did not reach a level of
significance. Pretreatment with NAC appeared to be more efficient than post-injury treat-
ment in protecting tissues against oxidative stress and inflammation in models of sepsis
and ischemia/reperfusion injury. Due to the mechanisms of action of NAC, it is conceiv-
able that it would be easier to prevent certain pathways from being activated rather than
to modulate already highly activated signals with redundant or alternative pathways.
The effects of NAC on renal oxygenation could be mediated by different mechanisms.
First, tissue NO levels were significantly increased after LPS infusion. By decreasing NO
levels in the cortex, NAC combined with fluid administration may improve microvascular
dysfunction, microvascular delivery of oxygen, and cortical oxygenation. Similarly, our
group previously demonstrated that the prostaglandin analog iloprost restored kidney
function in a rat model of endotoxemia and prevented the occurrence of hypoxic regions
[43]. The improvement of renal microvascular oxygenation was mediated in part by the
inhibition of inducible nitric oxide synthase expression in the kidney. Another major
player involved in endothelial dysfunction in sepsis-induced AKI is the widespread dam-
age to the endothelial glycocalyx, which may contribute to microvascular dysfunction via
impaired flow-dependent vasodilatation. Hyaluronic acid levels reflect the disruption of
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the glycocalyx [44]. In the present study, hyaluronic acid levels were significantly
increased after LPS infusion. Fluid resuscitation either with or without the addition of
NAC significantly dampened these levels. However, the decrease was more prevalent with
NAC treatments, but all of the significant benefits were due to the fluids as opposed to
NAC. NAC may still further improve microvascular oxygenation by decreasing endothe-
lial glycocalyx damage in addition to fluid resuscitation. In contrast, a clinical study moni-
tored volume loading with HES during elective surgery (20 ml/kg) and observed
increased serum glycocalyx biomarkers with HES alone [45]. In our study, fluid resuscita-
tion with HES seemed to be beneficial with regard to these biomarkers levels. One of the
main pathways of glycocalyx disruption is thought to be the formation of ROS such as
peroxynitrite. As NAC is a well-known scavenger of ROS, we measured the tissue levels
of malondialdehyde as a marker of lipid peroxidation. We did not observe a significant
decrease when using NAC-supplemented fluid compared to fluid alone. This result can
be explained because of the high dose of NAC in our study. Some authors have previously
suggested that high doses of NAC may increase MDA levels, whereas lower doses may
decrease MDA levels [46]. Additionally, a lack of effect of NAC on lipid peroxidation in
cases of established endotoxemia has been shown [47].
Limitations
In the light of the ongoing debate about the deleterious effects of HES on the kidney, a pos-
sible limitation of our study is our use of HES as a resuscitation fluid. However, the present
study is a mechanistic study wherein we investigated whether we could ameliorate the inflam-
matory effects of fluid administration in a sepsis model. In our experience, all fluids cause in-
flammation [48], and it is the fluid volume that determined the extent of injury. It could be
argued that we should have chosen a balanced crystalloid solution instead of a colloid-based
solution. However, crystalloid solutions have issues as well. For example, Ringer’s lactate
causes even more inflammation than HES [49, 50], and we would also have had to administer
a larger volume to maintain blood pressure causing more hemodilution. We chose a colloid
solution to keep the amount of fluid required to correct blood pressure to a minimum. We
could have used albumin, but even albumin can promote renal failure, as has been shown in a
recent study in cardiac surgery [51]. In conclusion, arguably, all fluids have deleterious effects
on the kidney to a greater or lesser extent. However, in this proof of concept study,
we hope to have introduced the idea that controlling the inflammatory component
imposed by fluids such as HES can be implemented by co-administration of an anti-
inflammatory drug such as NAC. Our results suggest that such an approach could be
used for other fluids, but this approach would require testing in subsequent studies.
Conclusions
In conclusion, the addition of NAC to fluid resuscitation may improve renal oxygenation
and attenuate microvascular dysfunction and AKI. Decreases of renal NO levels and hyalur-
onic acid levels may be involved in this beneficial effect. A therapeutic strategy combining
the macrovascular effects of fluids and the microvascular effects of NAC may be critical to
preventing sepsis-induced AKI. This study sets forth a new concept for changing the pro-
cedure of fluid resuscitation by the addition of antioxidant therapy during the initial phase
of resuscitation.
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